Moderna, Inc. (MRNA) Free cash flow 2016–2025
Moderna, Inc. (MRNA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$2.1BFY2025 · since FY2016: $33.6M → -$2.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.1B | +49.1% |
| FY2024 | -$4.1B | -6.0% |
| FY2023 | -$3.8B | -183.5% |
| FY2022 | $4.6B | -65.6% |
| FY2021 | $13.3B | +580.8% |
| FY2020 | $2.0B | +499.0% |
| FY2019 | -$491.0M | -12.5% |
| FY2018 | -$436.6M | -12.0% |
| FY2017 | -$389.9M | -1260.7% |
| FY2016 | $33.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice